| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,878 |
10,680 |
$373K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,982 |
2,955 |
$304K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,656 |
2,643 |
$282K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,206 |
2,178 |
$201K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,907 |
1,863 |
$187K |
| 92551 |
|
8,699 |
8,576 |
$136K |
| 90700 |
|
2,457 |
2,455 |
$63K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,706 |
14,245 |
$61K |
| 90461 |
|
3,450 |
3,431 |
$57K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,221 |
2,178 |
$29K |
| 90686 |
|
4,932 |
4,916 |
$28K |
| 99188 |
|
1,524 |
1,517 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,600 |
1,543 |
$14K |
| 90713 |
|
1,837 |
1,835 |
$9K |
| 90648 |
|
1,705 |
1,702 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,320 |
1,087 |
$7K |
| 90670 |
|
1,579 |
1,576 |
$7K |
| 99173 |
|
8,741 |
8,586 |
$7K |
| 90651 |
|
830 |
815 |
$5K |
| 90621 |
|
475 |
474 |
$4K |
| 0071A |
|
104 |
96 |
$4K |
| 90707 |
|
849 |
847 |
$4K |
| 90633 |
|
840 |
837 |
$4K |
| 90716 |
|
831 |
829 |
$4K |
| 90688 |
|
419 |
419 |
$4K |
| 90680 |
|
913 |
912 |
$3K |
| 0072A |
|
89 |
82 |
$3K |
| 90744 |
|
737 |
737 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
582 |
580 |
$3K |
| 3008F |
|
830 |
775 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| 90734 |
|
444 |
442 |
$2K |
| 90715 |
|
355 |
353 |
$2K |
| 96127 |
|
2,919 |
2,879 |
$2K |
| 90656 |
|
236 |
230 |
$1K |
| 90619 |
|
328 |
299 |
$1K |
| 90677 |
|
105 |
105 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
145 |
145 |
$901.08 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13 |
13 |
$544.44 |
| 0082A |
|
13 |
13 |
$520.00 |
| 99000 |
|
2,339 |
2,292 |
$260.10 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
13 |
$193.50 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
221 |
216 |
$190.13 |
| 96161 |
|
493 |
487 |
$157.30 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
39 |
39 |
$130.00 |
| 99072 |
|
17,517 |
16,661 |
$104.85 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
15 |
15 |
$76.20 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
43 |
42 |
$28.07 |
| 87081 |
|
75 |
73 |
$17.20 |
| 99051 |
|
825 |
800 |
$16.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
166 |
129 |
$11.51 |
| 91307 |
|
39 |
35 |
$0.00 |
| 96160 |
|
45 |
45 |
$0.00 |